AVAI

Atlas Venture Associates IX Portfolio holdings

AUM $11.8M
This Quarter Return
+3%
1 Year Return
-58.35%
3 Year Return
-89.8%
5 Year Return
-87.69%
10 Year Return
AUM
$595M
AUM Growth
+$595M
Cap. Flow
-$46.4M
Cap. Flow %
-7.8%
Top 10 Hldgs %
100%
Holding
7
New
Increased
1
Reduced
2
Closed

Top Buys

1
COGT icon
Cogent Biosciences
COGT
$5.58K

Sector Composition

1 Communication Services 74.77%
2 Healthcare 25.23%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
SKLZ icon
1
Skillz
SKLZ
$135M
$437M 73.46% 22,962,910 -321,493 -1% -$6.12M
NTLA icon
2
Intellia Therapeutics
NTLA
$1.22B
$89.4M 15.01% 1,113,376 -501,945 -31% -$40.3M
SURF
3
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$23M 3.86% 2,945,453
SPRO icon
4
Spero Therapeutics
SPRO
$116M
$20.3M 3.41% 1,376,968
SYBX icon
5
Synlogic
SYBX
$17M
$9.5M 1.6% 2,651,963
COGT icon
6
Cogent Biosciences
COGT
$1.69B
$8.05M 1.35% 916,832 +636 +0.1% +$5.58K
SNAP icon
7
Snap
SNAP
$12.1B
$7.85M 1.32% 150,160